Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-05-15Clinical Trial Update: The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients. [Phase 4]
Phase 4 trial investigating secondary benefits of a prostaglandin analog in Thyroid Eye Disease was withdrawn; the study also referenced ocu…
-
CLINICAL_TRIALS trial_result · 2018-04-20Clinical Trial Update: Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension [Phase 2]
A Phase 2 trial comparing a bimatoprost ocular insert to topical timolol solution in patients with primary open-angle glaucoma or ocular hyp…
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension [Phase 2]
A multi-center Phase II trial evaluating the safety and efficacy of DE-117 ophthalmic solution in adults with primary open-angle glaucoma or…
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating the safety and efficacy of DE-117 ophthalmic solution in patients with glaucoma or ocular hypertensio…
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 trial evaluating safety and efficacy of DE-117 ophthalmic solution in open-angle glaucoma or ocular hypertension completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution [Phase 2]
Phase 2 trial update showing nocturnal and diurnal intraocular pressure-lowering effects of netarsudil ophthalmic solution, with results pos…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure [Phase 2]
Phase 2 study comparing AR-13324 to Latanoprost in patients with elevated intraocular pressure has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3, double-masked trial of AR-13324 ophthalmic solution in ocular hypertension and open-angle glaucoma has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: KJ-TFC-004 Drug-drug Interaction Study [Phase 1]
Phase 1 study evaluating drug-drug interactions for KJ-TFC-004 in glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]
Results from a Phase 3 trial of netarsudil ophthalmic solution in glaucoma or ocular hypertension have been completed and posted.
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension [Phase 3]
Phase 3 study evaluating netarsudil ophthalmic solution in ocular hypertension and open-angle glaucoma completed with results posted in 2018…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension [Phase 3]
This clinical trial update reports results from a double-masked Phase 3 study of Netarsudil ophthalmic solution in adults with open-angle gl…
-
CLINICAL_TRIALS research · 2018-04-04Clinical Trial Update: Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops [NA]
A completed clinical trial evaluated whether taking over-the-counter non-steroidal anti-inflammatory drugs affects eye pressure in patients …
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]
This completed Phase 1/2 multicenter randomized trial evaluated the safety and preliminary efficacy of VS101, a subconjunctival latanoprost …
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT). [Phase 1]
A Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of RO5093151 in patients with primary o…
-
FDA approval · 2018-03-01FDA Approved: IOPIDINE 1% — Supplemental Application (Harrow Eye, LLC)
FDA approved a supplemental application for IOPIDINE 1% (apraclidine hydrochloride ophthalmic solution) from Harrow Eye, LLC.
-
FDA approval · 2018-03-01FDA Approved: APRACLONIDINE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for APRACLONIDINE submitted by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2018-02-22Clinical Trial Update: Study of AR-13324 in Patients With Elevated Intraocular Pressure [Phase 2]
Phase 2 trial results for AR-13324 in patients with elevated intraocular pressure have been posted.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG [Phase 2]
Phase 2 trial update for fixed-dose combinations of trabodenoson and latanoprost in adults with ocular hypertension or primary open-angle gl…
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: Laser-1st vs Drops-1st for Glaucoma and Ocular Hypertension [Phase 4]
A Phase 4 trial comparing Laser-1st vs Drops-1st strategies for primary open-angle glaucoma and ocular hypertension has completed.
-
FDA approval · 2017-12-18FDA Approved: RHOPRESSA — Original Application (Alcon Laboratories, Inc.)
FDA approved Rhopressa (netarsudil) from Alcon as an original NDA, indicated to reduce elevated intraocular pressure in adults with open-ang…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma [Phase 2]
A Phase II study evaluated whether trabodenoson adds to latanoprost in adults with ocular hypertension or primary open-angle glaucoma, and t…
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of Unilateral Latanoprost-loaded Punctual Plug -EXP-LP [NA]
A clinical trial update evaluating safety, tolerability and preliminary efficacy of a unilateral latanoprost-loaded punctual plug for glauco…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study [Phase 3]
Phase 3 FUJI study assessing the safety and efficacy of DE-117 in primary open-angle glaucoma or ocular hypertension patients who are non- o…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study [Phase 3]
Phase 3 long-term study of DE-117 ophthalmic solution, used alone and with timolol, in open-angle glaucoma or ocular hypertension has comple…